Molecular mechanisms of neurotransmitter release and its
Project Number1Z01NS002946-08
Contact PI/Project LeaderSHENG, ZU-HANG
Awardee OrganizationNATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Description
Abstract Text
To understand the molecular mechanisms underlying neurotransmitter release and its modulation, we are identifying proteins including Snapin, syntaphilin, and syntabulin that control the trafficking, targeting, and assembly of presynaptic release machinery at nerve terminals. We are further analyzing the functional roles of these proteins using molecular, biochemical, cell biological, and electrophysiological analysis (collaborating effort with other labs). The continued application of these approaches, in combination with a greater focus on cellular siRNA knockdown and genetic knockout studies, will allow us to better understand the regulatory pathways that govern the synaptic vesicle exocytosis and regulate synaptic strength.
Syntabulin is one of our major focuses during the fiscal year 2004. The process of neurotransmitter release involves a series of protein-protein interactions between the membranes of synaptic vesicles and presynaptic terminals. Syntaxin-1 is a key component of the membrane fusion machinery at the presynaptic plasma membrane. Presynaptic proteins involved in synaptic vesicle exocytosis are synthesized in the soma of neurons, incorporate into transport cargo vesicles, and undergo proper trafficking to the synaptic terminal. However, little is known regarding the mechanisms by which cargo organelles containing vesicle release machinery physically associate with their microtubule-based transport motors. In an effort to characterize syntaphilin isoforms, we have identified a gene encoding a novel syntaxin-binding protein named syntabulin. Syntabulin attaches syntaxin-containing vesicles to microtubules and migrates with syntaxin within the processes of hippocampal neurons. Knockdown of syntabulin expression with targeted siRNA or interference of the syntabulin-syntaxin interaction inhibit attachment of syntaxin-cargo vesicles to microtubules and reduce syntaxin-1 distribution in the neuronal processes. Furthermore, molecular motor protein kinesin I KHC binds to syntabulin and associates with syntabulin-linked syntaxin vesicles in vivo. These findings suggest that syntabulin acts as a linker molecule that attaches syntaxin-cargo vesicles to motor kinesin I, enabling the transport of syntaxin-1 to neuronal processes. Our findings provide new clues to the cellular mechanisms that are likely to underlie the specific trafficking of synaptic cargoes.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
biological signal transductioncalcium channelcalmodulin dependent protein kinasecyclic AMPendocytosisexocytosisimmunocytochemistryimmunoprecipitationnerve /myelin proteinneural plasticityneural transmissionneuronsneurotransmitter transportphosphorylationpolymerase chain reactionprotein kinase Aprotein protein interactionprotein quantitation /detectionprotein structure functionsecond messengerssmall interfering RNAsynaptic vesiclessynaptotagminsyntaxintissue /cell culturewestern blottings
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
UEI
Project Start Date
Project End Date
Budget Start Date
Budget End Date
Project Funding Information for 2004
Total Funding
Direct Costs
Indirect Costs
Sub Projects
No Sub Projects information available for 1Z01NS002946-08
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1Z01NS002946-08
Patents
No Patents information available for 1Z01NS002946-08
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1Z01NS002946-08
Clinical Studies
No Clinical Studies information available for 1Z01NS002946-08
News and More
Related News Releases
No news release information available for 1Z01NS002946-08
History
No Historical information available for 1Z01NS002946-08
Similar Projects
No Similar Projects information available for 1Z01NS002946-08